151 related articles for article (PubMed ID: 31961866)
1. Pathological roles of MRP14 in anemia and splenomegaly during experimental visceral leishmaniasis.
Ishizuka K; Fujii W; Azuma N; Mizobuchi H; Morimoto A; Sanjoba C; Matsumoto Y; Goto Y
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0008020. PubMed ID: 31961866
[TBL] [Abstract][Full Text] [Related]
2. B-cell activating factor deficiency suppresses splenomegaly during Leishmania donovani infection.
Omachi S; Fujii W; Azuma N; Morimoto A; Sanjoba C; Matsumoto Y; Goto Y
Biochem Biophys Res Commun; 2017 Aug; 489(4):528-533. PubMed ID: 28583852
[TBL] [Abstract][Full Text] [Related]
3. The accumulation of macrophages expressing myeloid-related protein 8 (MRP8) and MRP14 in the spleen of BALB/cA mice during infection with Plasmodium berghei.
Mizobuchi H; Yamakoshi S; Omachi S; Osada Y; Sanjoba C; Goto Y; Matsumoto Y
Exp Parasitol; 2014 Mar; 138():1-8. PubMed ID: 24440297
[TBL] [Abstract][Full Text] [Related]
4. Adhesion of MRP8/14 to amastigotes in skin lesions of Leishmania major-infected mice.
Goto Y; Sanjoba C; Asada M; Saeki K; Onodera T; Matsumoto Y
Exp Parasitol; 2008 May; 119(1):80-6. PubMed ID: 18272153
[TBL] [Abstract][Full Text] [Related]
5. IRF-5 Expression in Myeloid Cells Is Required for Splenomegaly in
Mai LT; Smans M; Silva-Barrios S; Fabié A; Stäger S
Front Immunol; 2019; 10():3071. PubMed ID: 32038622
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of macrophages expressing MRP8 and MRP14 in skin lesions during Leishmania major infection in BALB/c and RAG-2 knockout mice.
Goto Y; Sanjoba C; Arakaki N; Okamoto M; Saeki K; Onodera T; Ito M; Matsumoto Y
Parasitol Int; 2007 Sep; 56(3):231-4. PubMed ID: 17409015
[TBL] [Abstract][Full Text] [Related]
7. Ineffective elimination of Leishmania major by inflammatory (MRP14-positive) subtype of monocytic cells.
Steinbrink K; Schönlau F; Rescher U; Henseleit U; Vogel T; Sorg C; Sunderkötter C
Immunobiology; 2000 Nov; 202(5):442-59. PubMed ID: 11205374
[TBL] [Abstract][Full Text] [Related]
8. Infection pattern and immune response in the spleen and liver of BALB/c mice intracardially infected with Leishmania donovani amastigotes.
Mukherjee P; Ghosh AK; Ghose AC
Immunol Lett; 2003 Apr; 86(2):131-8. PubMed ID: 12644314
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of p110δ isoform of the phosphoinositide 3 kinase leads to enhanced resistance to Leishmania donovani.
Khadem F; Mou Z; Liu D; Varikuti S; Satoskar A; Uzonna JE
PLoS Negl Trop Dis; 2014 Jun; 8(6):e2951. PubMed ID: 24945303
[TBL] [Abstract][Full Text] [Related]
10. Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey.
Özbilgin A; Harman M; Karakuş M; Bart A; Töz S; Kurt Ö; Çavuş İ; Polat E; Gündüz C; Van Gool T; Özbel Y
Acta Trop; 2017 Sep; 173():90-96. PubMed ID: 28587839
[TBL] [Abstract][Full Text] [Related]
11. Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani.
Morimoto A; Omachi S; Osada Y; Chambers JK; Uchida K; Sanjoba C; Matsumoto Y; Goto Y
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004505. PubMed ID: 26942577
[TBL] [Abstract][Full Text] [Related]
12. HIF-1α hampers dendritic cell function and Th1 generation during chronic visceral leishmaniasis.
Hammami A; Abidin BM; Heinonen KM; Stäger S
Sci Rep; 2018 Feb; 8(1):3500. PubMed ID: 29472618
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory CD11b
Nagai K; Fujii W; Yamagishi J; Sanjoba C; Goto Y
Pathogens; 2024 Mar; 13(3):. PubMed ID: 38535575
[TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection.
Ghosh J; Bose M; Roy S; Bhattacharyya SN
Cell Host Microbe; 2013 Mar; 13(3):277-88. PubMed ID: 23498953
[TBL] [Abstract][Full Text] [Related]
15. B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology.
Smelt SC; Cotterell SE; Engwerda CR; Kaye PM
J Immunol; 2000 Apr; 164(7):3681-8. PubMed ID: 10725726
[TBL] [Abstract][Full Text] [Related]
16. Parasitic load determination by differential expressions of 5-lipoxygenase and PGE2 synthases in visceral leishmaniasis.
Saini S; Singh B; Prakash S; Kumari S; Kureel AK; Dube A; Sahasrabuddhe AA; Rai AK
Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106390. PubMed ID: 31726220
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.
Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM
Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077
[TBL] [Abstract][Full Text] [Related]
18. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
[TBL] [Abstract][Full Text] [Related]
19. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response.
Melby PC; Chandrasekar B; Zhao W; Coe JE
J Immunol; 2001 Feb; 166(3):1912-20. PubMed ID: 11160239
[TBL] [Abstract][Full Text] [Related]
20. Screening Leishmania donovani complex-specific genes required for visceral disease.
Zhang WW; Matlashewski G
Methods Mol Biol; 2015; 1201():339-61. PubMed ID: 25388124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
